MarketsandMarkets Conferences Blogs
The 4th Annual MarketsandMarkets Next-Gen Bioprocessing Conference on the 20th & 21st of October 2022 is just about 12 weeks away & we’re gleaming with excitement with what lies in store. An opportunity to witness over 15+ industry experts delve deep into key topics such as cell culture & bioproduction, downstream processing & continuous biomanufacturing […]
The 4th Annual MarketsandMarkets Next-Gen Bioprocessing Conference on the 20th & 21st of October 2022 aims to delve deep into defining trends & innovation withing the bioprocessing ecosystem around major domains like cell culture & bioproduction, downstream processing & continuous biomanufacturing and cell and gene therapy analytics. Just under 12 weeks remain till we go […]
Boston plays host to the 4th Annual MarketsandMarkets Next-Gen Bioprocessing Conference on the 20th & 21st of October 2022 and we’re literally counting down the days! With over 100+ attendees & in-depth case studies & keynote presentations from 15+ leading industry experts, the event promises to deliver a comprehensively enriching experience! As we keenly await […]
Matt Davis PhD joined Gritstone Oncology (NASDAQ: GRTS) in 2015 and is currently the Director of Molecular Biology and Sequencing responsible for various neo-antigen discovery and translational genomics efforts. Prior to Gritstone, Dr. Davis conducted post-doctoral research at Warp Drive Bio in the discovery biology group. He holds a PhD in Genetics from Yale with […]
Ning is a bioinformatics scientist at Arcus Biosciences, where he is responsible for drug discovery, target identification, and indication prioritization in multiple immune-oncology drug programs. Notably, Ning pioneered the 3D organoids based drug response prediction technology, which largely facilitated cancer model selection. During his PhD, he studied with Professor Alexander Hoffmann at UCLA, where he […]
Grace Zhao is a co-founder of Avida Biomed, a biotech start-up specializing in genomic technology innovation for molecular diagnostics. At Avida, Grace co-invented Point-n-Seq, a new platform technology to advance liquid biopsy for early detection of cancer and other diseases. Utilizing the ultra-efficient, hybridization-based pre-amplification enrichment of target molecules from nanogram level cell free DNA […]
3rd Annual MarketsandMarkets Cell & Gene Therapy Manufacturing Virtual Conference to be held on 28th – 29th October 2021 will host industry giants like Advanced Cell & Gene Therapy LLC, Cell & Gene Therapy Consulting LLC, panCella, Sigilon Inc, Biotechnology Biopharmaceuticals and many more. The global cell & gene therapy manufacturing services market size is […]
February 26th – MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT on the March 11, 2021 will hostindustry giants Fresenius Kabi, Charles River Laboratories, GenScript ProBio, Pall Corporation and MilliporeSigma to present their thoughts on the Top 10 Disruptions Through BioPharma Manufacturing in the next 5 year! MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT will gather 100+ professionals […]
London, UK July 29, 2019 – MarketsandMarkets recently interviewed Gavin Reynolds, Professor Emeritus, Queen’s University Belfast, UK regarding the 4th Annual MarketsandMarkets Epigenetics Congress, taking place on 3-4 October 2019 at Radisson Blu Edwardian, Grafton, London, UK. Gavin Reynolds is Honorary Professor at Sheffield Hallam University and Professor Emeritus, previously Chair of Neuroscience, at Queen’s University Belfast. […]
Catalent has approved AveXis that, a Novartis Company to use its brand-new commercial manufacturing center near Baltimore-Washington International Airport as an extra site production site for its spinal muscular atrophy (SMA) gene therapy Zolgensma® (onasemnogene abeparvovec-xioi). A collaboration contract was signed by Catalent and AveXis to ensure long term strategic agreement but has not been […]
